2M3U

Solution-state NMR structure of cataract-related human gamma(S)-crystallin point variant G18V

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	10 mM acetic acid, 2 mM 2,2',3,3'-D4 TSP, 0.05 % sodium azide, 1.50 mM [U-13C; U-15N] (gamma)S-G18V	90% H2O/10% D2O		4.5	ambient	295
2	2D 1H-13C HSQC aliphatic	10 mM acetic acid, 2 mM 2,2',3,3'-D4 TSP, 0.05 % sodium azide, 1.50 mM [U-13C; U-15N] (gamma)S-G18V	90% H2O/10% D2O		4.5	ambient	295
3	2D 1H-13C HSQC aromatic	10 mM acetic acid, 2 mM 2,2',3,3'-D4 TSP, 0.05 % sodium azide, 1.50 mM [U-13C; U-15N] (gamma)S-G18V	90% H2O/10% D2O		4.5	ambient	295
4	3D HNCACB	10 mM acetic acid, 2 mM 2,2',3,3'-D4 TSP, 0.05 % sodium azide, 1.50 mM [U-13C; U-15N] (gamma)S-G18V	90% H2O/10% D2O		4.5	ambient	295
5	3D CBCA(CO)NH	10 mM acetic acid, 2 mM 2,2',3,3'-D4 TSP, 0.05 % sodium azide, 1.50 mM [U-13C; U-15N] (gamma)S-G18V	90% H2O/10% D2O		4.5	ambient	295
6	3D HNCO	10 mM acetic acid, 2 mM 2,2',3,3'-D4 TSP, 0.05 % sodium azide, 1.50 mM [U-13C; U-15N] (gamma)S-G18V	90% H2O/10% D2O		4.5	ambient	295
7	3D HCCH-TOCSY	10 mM acetic acid, 2 mM 2,2',3,3'-D4 TSP, 0.05 % sodium azide, 1.50 mM [U-13C; U-15N] (gamma)S-G18V	90% H2O/10% D2O		4.5	ambient	295
8	3D HCCH-COSY	10 mM acetic acid, 2 mM 2,2',3,3'-D4 TSP, 0.05 % sodium azide, 1.50 mM [U-13C; U-15N] (gamma)S-G18V	90% H2O/10% D2O		4.5	ambient	295
9	3D 1H-15N NOESY	10 mM acetic acid, 2 mM 2,2',3,3'-D4 TSP, 0.05 % sodium azide, 1.50 mM [U-13C; U-15N] (gamma)S-G18V	90% H2O/10% D2O		4.5	ambient	295
10	3D 1H-13C NOESY aliphatic	10 mM acetic acid, 2 mM 2,2',3,3'-D4 TSP, 0.05 % sodium azide, 1.50 mM [U-13C; U-15N] (gamma)S-G18V	90% H2O/10% D2O		4.5	ambient	295
11	3D 1H-13C NOESY aromatic	10 mM acetic acid, 2 mM 2,2',3,3'-D4 TSP, 0.05 % sodium azide, 1.50 mM [U-13C; U-15N] (gamma)S-G18V	90% H2O/10% D2O		4.5	ambient	295
12	2D 1H-15N HSQC	10 mM acetic acid, 2 mM 2,2',3,3'-D4 TSP, 0.05 % sodium azide, 7.5 % DIOTPC, 2.5 % DIOHPC, 2.0 mM [U-13C; U-15N] (gamma)S-G18V	90% H2O/10% D2O		4.5	ambient	303
13	3D HNHA	10 mM acetic acid, 2 mM 2,2',3,3'-D4 TSP, 0.05 % sodium azide, 1.50 mM [U-13C; U-15N] (gamma)S-G18V	90% H2O/10% D2O		4.5	ambient	295

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	800

NMR Refinement
Method	Details	Software
simulated annealing		VNMR

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	21
Representative Model	1 (minimized average structure)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	VNMR		Varian
2	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	chemical shift assignment	Sparky		Goddard
4	chemical shift assignment	CcpNmr Analysis		CCPN
5	data analysis	CcpNmr Analysis		CCPN
6	peak picking	CcpNmr Analysis		CCPN
7	refinement	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore
8	structure solution	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.